Add to ORKGThe holy grail of evidence has become all pervasive in the global HIV response. The drive for universalising knowledge on what works, derived from the emergence of ‘high quality’ evidence for biomedical prevention technologies, is now so entrenched in policy that sensitive appraisals of the ways in which interventions are engaged with and made to work in different contexts are being overlooked
The development of pharmaceutical HIV prevention technologies (PPTs) over the last five years has ge...
International audienceStrengthening universal HIV 'test-and-treat' approaches with social science re...
While community mobilisation (CM) is increasingly advocated for HIV prevention, its impact on measur...
Here, we address the governance of the HIV and AIDS pandemic with reference to the social aspects of...
Translating evidence from clinical trials to routine care can take many years, particularly in low-i...
The challenges of transferring biomedical advances and non-biomedical technological innovations in H...
This paper has two objectives. The first is to provide a review of the discourses about the religiou...
Recent years have seen the re-emergence of charges of AIDS exceptionalism in response to ‘revolution...
Despite the long-running HIV/AIDS campaigns by the Singapore Ministry of Health, every year, more Si...
Purpose: Mass media HIV testing interventions are effective in increasing testing, but there has b...
Introduction: The generation of robust evidence has been emphasised as a priority for global health....
Evidence of the efficacy of HIV treatment as prevention (TasP) precipitated a highly optimistic glob...
This paper presents findings from a case study of two different policy development processes within ...
The relationship between conflict, sexual violence and the spread of HIV is an important concern for...
In this paper, we contrast two emergences of the concept of ‘uninfectious’ (that pharmaceuticals can...
The development of pharmaceutical HIV prevention technologies (PPTs) over the last five years has ge...
International audienceStrengthening universal HIV 'test-and-treat' approaches with social science re...
While community mobilisation (CM) is increasingly advocated for HIV prevention, its impact on measur...
Here, we address the governance of the HIV and AIDS pandemic with reference to the social aspects of...
Translating evidence from clinical trials to routine care can take many years, particularly in low-i...
The challenges of transferring biomedical advances and non-biomedical technological innovations in H...
This paper has two objectives. The first is to provide a review of the discourses about the religiou...
Recent years have seen the re-emergence of charges of AIDS exceptionalism in response to ‘revolution...
Despite the long-running HIV/AIDS campaigns by the Singapore Ministry of Health, every year, more Si...
Purpose: Mass media HIV testing interventions are effective in increasing testing, but there has b...
Introduction: The generation of robust evidence has been emphasised as a priority for global health....
Evidence of the efficacy of HIV treatment as prevention (TasP) precipitated a highly optimistic glob...
This paper presents findings from a case study of two different policy development processes within ...
The relationship between conflict, sexual violence and the spread of HIV is an important concern for...
In this paper, we contrast two emergences of the concept of ‘uninfectious’ (that pharmaceuticals can...
The development of pharmaceutical HIV prevention technologies (PPTs) over the last five years has ge...
International audienceStrengthening universal HIV 'test-and-treat' approaches with social science re...
While community mobilisation (CM) is increasingly advocated for HIV prevention, its impact on measur...